Clinical Trials Directory

Trials / Completed

CompletedNCT04071808

Painless Myocardial Ischemia in Diabetic Patients.

Changes of Plasma Orphanin and Norepinephrine Levels in Patients With Painless Myocardial Ischemia and Diabetes Mellitus.

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Second Hospital of Shanxi Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISA TestThe levels of orphanin and norepinephrine in blood of diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy were measured.

Timeline

Start date
2019-10-01
Primary completion
2019-12-30
Completion
2020-03-01
First posted
2019-08-28
Last updated
2022-04-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04071808. Inclusion in this directory is not an endorsement.

Painless Myocardial Ischemia in Diabetic Patients. (NCT04071808) · Clinical Trials Directory